Study reveals how macrophages affect cardiac fibroblast fate post-myocardial infarction

The research uncovers a previously unappreciated mechanism by which macrophages influence the fate of CFs post-MI. It demonstrates that macrophage-derived IFN-β stimulates the IFN-β-IFNAR-p-STAT1 axis in CFs, leading to the upregulation of chemokines (CCL2/7/12) that attract more macrophages. This process forms a positive feedback loop that impedes cardiac reprogramming. The study also shows that inhibiting the IFN signaling pathway or depleting macrophages can downregulate STAT1 activation and improve reprogramming efficiency, promoting cardiac regeneration.
Key findings from the study include:

  1. Role of IFN-β in Cardiac Reprogramming: Macrophage-secreted IFN-β inhibits the reprogramming of CFs to CMs in vivo by activating the IFN-β-IFNAR-p-STAT1 pathway, which interferes with GATA4's function in cardiac gene transcription.
  2. Positive Feedback Loop: Activated CFs secrete CCL2/7/12 chemokines that recruit additional macrophages, which in turn secrete more IFN-β, enhancing STAT1 phosphorylation and creating a self-reinforcing loop that suppresses reprogramming.
  3. Inhibition of IFN Signaling Enhances Reprogramming: Blocking the IFN signaling pathway or depleting macrophages reduces STAT1 activation and facilitates cardiac reprogramming, indicating potential therapeutic targets for cardiac regeneration.

This study elucidates the complex interplay between macrophages and CFs in the MI microenvironment, highlighting the role of the IFN-β-IFNAR-p-STAT1 signaling pathway as a critical barrier to cardiac reprogramming. By demonstrating that disruption of this pathway improves reprogramming efficiency and cardiac function in vivo, the research opens new avenues for developing strategies to enhance cardiac regeneration. The findings contribute to understanding the molecular mechanisms underlying cardiac repair and suggest that targeting the IFN signaling pathway could be a promising therapeutic approach for myocardial infarction. The work entitled " Macrophages suppress cardiac reprogramming of fibroblasts in vivo via IFN-mediated intercellular self-stimulating circuit" was published on Protein & Cell (published on Mar. 26, 2024).

Source:
Journal reference:

Wang, H., et al. (2024). Macrophages suppress cardiac reprogramming of fibroblasts in vivo via IFN-mediated intercellular self-stimulating circuit. Protein & Cell. doi.org/10.1093/procel/pwae013.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
How can microdialysis benefit drug development?